Two Schedules of Hepatitis B Vaccination in Predialysis Chronic Renal Failure Patients

Summary

Patients with chronic renal disease have to be vaccinated as soon as dialysis is forestalled and this could improve seroconversion rate of hepatitis B vaccination. In this study, the investigators aimed to compare seroconversion rates and immune response rates using four doses of 40 μg and three doses of 20 μg of Euvax B recombinant hepatitis B surface antigen (HBsAg) vaccine given to predialysis CKD patients.

Timeline

Start

2008-10

Primary completion

2008-10

Completion

2008-10

Drugs

Indications